SSRIs (Selective Serotonin Reuptake Inhibitors) are specific types of drugs that are most commonly utilized to treat depression and anxiety disorders. The drugs work to increase the amount of the neurotransmitter serotonin by preventing or inhibiting its reuptake. By preventing the reuptake of serotonin in the pre-synaptic neurons, this allows for increased serotonin in the …
SNRIs (Selective Serotonin Reuptake Inhibitors) are also known as dual-reuptake inhibitors because they prevent the reuptake of multiple neurotransmitters in the brain. Most of the second-generation antidepressants are classified as “SSRI,” meaning they focus solely on preventing the reuptake of serotonin. SNRI drugs continue to prevent the reuptake of serotonin, but also focus on another …
Atypical antidepressants are unique from other classes of antidepressants based on pharmacological properties. These days, the most common antidepressants fit into one of a few categories: SSRIs/SNRIs, TCAs, and MAOIs. Respectively these are: selective-serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), tricyclics (TCAs), and monoamine oxidase inhibitors (MAOIs). SSRIs and SNRIs are considered the …
Most people suffering from depression are seeking treatments that are safe. Although many treatments such as medications are relatively safe, they can result in unwanted negative side effects and difficult withdrawals. In most cases, it is better to attempt treating depression with therapy and natural methods prior to trying antidepressant drugs. It should also be …
When it comes to depression, most people are looking for a treatment that allows them to feel happier, while minimizing potential side effects. There are many antidepressants on the market, and while some may work slightly better than others, most research indicates that the efficacy among approved drugs is very similar. If you are looking …
There is mounting preliminary evidence suggesting that Botox treatment for depression works quite well. In fact just receiving one injection of cosmetic botulinum toxin (BTX) could ward off the blues. Although only smaller studies have been conducted, most researchers believe that Botox treatments target facial muscles that are responsible for both expressing and regulating emotions. …
ALKS-5461 is a new drug that is being developed by the company Alkermes as an alternative to SSRI’s for the treatment of depression. ALKS-5461 (its trial name) is a combination of both buprenorphine (suboxone) and samidorphan, and is regarded as a non-addictive opioid modulator and antidepressant. It is currently being developed specifically as an antidepressant …